5 Pharmaceutical Stocks to Buy Today According to Tiger Cub Billionaire Lee Ainslie

1. Atara Biotherapeutics, Inc. (NASDAQ: ATRA)

Maverick Capital’s Stake Value: $119,808,000
Percent of Maverick Capital’s 13F Portfolio: 1.12%
Number of Hedge Fund Holders: 20

Atara Biotherapeutics, Inc. (NASDAQ: ATRA) is a biotechnology company that focuses on the development of transformative therapies for patients with autoimmune disease, solid tumors, and cancers.

In Q2, Maverick Capital holds over 7.7 million shares in Atara Biotherapeutics, Inc. (NASDAQ: ATRA), worth approximately $120 million. The company accounts for 1.12% of the hedge fund’s 13F portfolio. In May, JPMorgan conducted the physician’s survey regarding the company’s phase 1 results in progressive multiple sclerosis and found the clinical significance achievable for phase 2. The firm upgraded Atara Biotherapeutics, Inc. (NASDAQ: ATRA) to ‘Overweight’ and also lifted its price target on the stock to $29. For Q2 2021, Atara Biotherapeutics, Inc. (NASDAQ: ATRA) posted revenue of $3.87 million. The stock has delivered a 4.55% return in the past year.

As of Q2 2021, 20 hedge funds tracked by Insider Monkey have positions in Atara Biotherapeutics, Inc. (NASDAQ: ATRA), the same as in the previous quarter. The total value of these stakes is $458.6 million.

You can also take a look at 10 Best Stocks To Buy According To Billionaire Larry Robbins and 10 Best Stocks To Buy Now According To Quant Billionaires.

Follow Insider Monkey on Twitter